Please login to the form below

Not currently logged in
Email:
Password:

Cytovation expands management team

Raj Airey and Federico Grego join the Norwegian biotech

Cytovation Raj AireyNorwegian skin disease specialist Cytovation has appointed Raj Airey and Federico Grego to its management team.

Airey (pictured right) becomes venture developer at the biotech, bringing 28 years of healthcare operating experience at firms including Baxter and Pfizer across the UK, Europe and India.

He founded home care and telehealth company Wizzcare Home Health Solutions based in India, and is a co-founder of the country's first healthcare accelerator online platform, Health Start, for which he serves as a board member.

Cytovation Federico GregoMeanwhile, Federico Grego (pictured left) joins Cytovation as strategic counsel, with almost 20 years of experience in business development, innovation management, marketing and sales in the biopharmaceutical sector.

Grego is currently chief executive officer of Spire Bioventures, a global healthcare consultancy and mentoring service, and has previously held a number of management positions at Spanish allergy specialist Laboratorios LETI.

Kjell Inge Arnevig, chief executive of Cytovation, said: “We are pleased to welcome Federico and Raj to the Cytovation management team.

“We are thrilled to have them both join the team at this exciting time in Cytovation's development. Both have an impressive track record and extensive experience in the sector, which we are confident will help Cytovation achieve its goals.”

6th October 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...